Cite
HARVARD Citation
Kasamon, Y. et al. (2018). FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis. Oncologist. pp. 1511-1519. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kasamon, Y. et al. (2018). FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis. Oncologist. pp. 1511-1519. [Online].